i. INTRODUCTION more difficult than had been anticipated in the 1970's. This is in part because some systems were Sophisticated medical computer applications designed by computer advocates with idealistic depending directly on disciplines of Computer Scigoals such as 'eliminating the paper medical reence such as artificial intelligence, mathematical cord', rather than being specifically developed to simulation, and information theory have made irasolve in a cost-effective manner the practical inforportant contributions to medical practice and remation-handling problems perceived by the insearch. However, many of the most frustrating tended users. information management problems commonly enWe have designed a computer-based informacountered by clinicians are in principle amenable tion processing system to solve data management to solution by the application of relatively familiar problems encountered in clinical research. 'Clini-'data base management' methodology that is cal research' involves administering new treatwidely employed in industry and commerce. The ments to patients and observing responses over successful utilization of such methods to manage time in order to judge the efficacy of the treatclinical information has proven to be slower and merits. Often hundreds of patients on a variety c,f experimental treatments have to be followed with respect to a large number of "response variables' for months or ~,ears, and stat'~stical comparisons of Surprisingly, there has been relativel) little attenof computer efforts in the area to date will be tion given to the application of modern informaexamined, and finally we will describe a new Protion management techniques to optimize data captocol Management System (PMS) we have desigture and analy,~is in clinical research, although it is ned to assist with data handling in clinical retrue that many large clinical research projects use search. computers for final statistical calculations, after labour-intensive data collection and tabulation steps.
INFORMATION MANAGEMENT PROBMuch clinical research is conducted in the form
LEMS IN CLINICAL TRIALS AS PERof 'clinic'al trials" of new treatments. Typically. the CEIVED BY RESEARCHERS new treatment is described in a "treatment protocol'. which specifies the characteristics of patients
lnadequac~ of traditional medical records
that are appropriate candidates for the experimental treatment, the nature of the treatment and hog'
As in all m~entific research, successful compleit is is to be administered over time. and what ti, of a .:linical trial depends in part on careful clinical and laborator3' l=arameters are to be obd,~.amentation of procedures performed and reserved in order to monitor response and/or toxicsuhs observed. However, unlike laboratory investiity. Designs of clinical trials are generally comgation, where this can be done with relatively little plex: issues related to randomization of patients, distractior,, the 'laboratory' of clinical trials is control groups, informed consent, and stratificaoften a busy hospital clinic, where the research tion of patients must be specifically addressed, component must be closely lil~ked to the medical However. the various different clinical trial methcare function, and where observations are generodologies generally have similar kinds of informaally recorded somewhat haphazardly in the palion collection arm processing requirements, altients' medical records. though specific details vary from trial to trial, it must be explicitly recognized that under these The magnitude of effort invol~ed in adminis',crcircumstances, the medical record is being called ing clinical research projects i~ often underestiupon to assume a new role. it is not being used mated. The National L~brarv of Medicine (USA)
,,imply to dtx:ument a single patient's progress as has catalogued over 2000 treatment pro:ocois beintan individual (tl:t. traditional function). I,ut also to tested in clinical trials in cancer research alone, form the basis for integrating data gathered on Each of these typically involves betx~een 10 and many patiznts ir~ order to study the relative ef-1000 patients, and each requires collection and ficacy of differer.t treatments. That is. the data is analysis of clinical data on every patient involved, recorded not simply with the objective of docuSince formal clinical trials first were employed mtntmg each patient's disease, but also to allow in the 1940"s to study the efficacy of anti-tubercufo" subse¢~uent evaluation of the treatment given. lous drugs [ l] , the,, have become generally accepted While : ,,ditional "free format' paper medical as the ultimate proving-ground of new medical records r, ly or may not represent an adequate and treatments. While there are continuing controverit, expensive way to fulfill the objective of docusies with regards to various different ways to menting a patient's illness, they clearly do not organize trials, it would appear that clinical trials r,::,i~ii convenient manipulation of accumulated of one kind or another will remain th.. benchmarks clinical observations to compare groups of patients for evaluatingnew medical treatment,s as is required ill clinical research. Thus, a Optimum use of computers to aid .vith data i :.our-intensive and error-prone step of methodimana3ement in clinical trials is not widc,pread at tally extrac:ing data from medical records at the present. In this paper, we will outline the r¢a';e, ns ~.'onclusio, of a clinical trial follow-up period. for this after reviewing the problems of informaprior to analysis of the data, has become a cornlion management in clinical trials as perceived by mon task. the researcher. ,qom~ .:,f ~ne successes and failure~, clan only has a small number of patients in a given to improve long-term survival of breast ct,',.=cr clinical trial, he will not have the protocol details patients, it becomes necessary to follow hundreds at his fingertips, and he may in fact find the of patients for m~Lny years, particularly if anticinterruption of his busy clinic to consult a protocol ipated differences in efficacy are expected to possimanual to be a significant inconvenience. This bly be statistically significant, but nevertheless not inconvenience is compounded from the practionlarge, er's point-of-vie~ if he must see, in a really,tic Epidemiologists and statisticians face chaiexample, eight patients in 2 h, two of whom arc lenges in the design of such clinical trials; data enrolled in protocol A, one in B, one in C. ¢ne in processing consultants are now being called op to D, and three who are being treated without referemploy modern data capture and data base ence to protocols. The necessity of referring to management techniques to facilitate their execufour manuals within 2 h to ensure that the relevar, t lion. This contrasts with the situation a decade protocol details are adhered to in each case can be ago, where computers were merely used for stab a nuisance, and often either the line-up in the isticai calculations after data was "manually" col~aiting room will increase, or, in the interests of lected, tabulated, and submitted, expedienc~, accurate adherence t~ the protocol Difficulties with collection and tabulation of will be sacrificed. large quantities of clinical data can lead to iraAnother. more obvious, prob'cm ;.~oiving data 'oortant secondary problems for those organizing collection in "multicentre' trials relates to delays ,n trials. Often, the additional clerical workload imsubmission of data from the peripheral sites to the posed on medical professionals and their assistants central office for analysis, la theory, this need not ,r, capturing data becomes so time-consuming in be an obstacle, as there is g-nerally no need for the: the context of a busy practice that accurac:¢ in central data base to be update, I daily, but in recording suffers. Furthermore, if informationpracti~:e co-ordinatocs c~f trials often experience gathering chores are perceived as too troublesome, significant delays when ~hey have to await the organizers of clinical trials find it harder to persubmissior of late data. It is not our intention here to comprehensively tiara periodically as it "lccumulates over time.
review all existing software that is employed to aid Certain trials run for needlessly long times bewith information processing in clinical research. cause of a lack of availability of interim results, but rather to highlight certain general points reTher,: is now interest in dyn:lmically monitvring garding existing systems, using a few examples. It clinical trials, to allow trial directors to stop remust be emphazied that computer-aided data cruitment of new patients as ,.oon as an adequate processing enjoys widespread use in clinical trials, number of patients has been followed for a suffiand that mu~:h has been achieved. Howe,vet, in cient length of time to allow valid conclusions to most instance,; there is a gap between 'aaequate' he drawn [3] . Where applicable, this is a signifidata processing support (often achieved) and 'extant way of minimizing the co,,t of clir.,cal recellent' data processing support, which often seems .,earch. but it obviously requires the availab, litv of to be within reach, but rarely has been accomfrequent acc~.:s to interim results as data accuplished to date. Wiederhold [4] ha:, recently mulates. From an ethical point ot view. it is destrareviewed medical data base management systems, ble to use interim results to enabie the detection of inchtding certain applications in clinical research. differences between various treatment groups with respect to response or toxicity as soon as possible.
.¢. I. S~'stems that do too httle Even though the use of computer systems to prtxess clinical trial data using statistical soft~,.are Much data processing in clinical research has is widespread, the data capture and tabulation been dotle using large computer systems and early steps are g..enerally not automated, and the p: "iversions of commercially available statistical sion of interim results requires repetition of the software packages such as SPSS (Statistical inefficient step of'manuar cxtra.ztion of data from Package for Social Sciences) t,r SAS (Statistical med,cal records or forms.
Analysis System). This kind of data processing is Furthermore. the analvsi.-" of ~.]ata mt~st often bt.
successful in accomplishing the limited objectives delegated to computer persor~ne; who, use statistr of performing calculations and summarizing data cal software to generate reporI~ which are ther in a presentable form. However. many of the presented to chnicai researcl,ers. This process reproblems of information processing in clinical triquires excellent understaad,ng and rapport beais that frustrate physicians occur at the early tween those "a~kiag the questions" an0 those with steps of data capture and entry, and batch-oriented a~.tuai access to the r,~, data. Where this rapport statistical software is ~lot designed to address these 24"/ areas. Furthermore, we have already seen that goals must be regarded as controversial at this such systems generally do not make the collected time. Systems that are primarily designed to help data directly available to the researcher when analphysicians with the paperwork associated with their ysis takes place: often access to the data is by usual clinical practice will likely be best receieved. means of a non-interactive program run by computer support personnel.
3.3. Protocol-specific system;
Systems that do too much
Many l:,rotocol-specific systems have been deLarge-scale general-purpose computer systems signed and used successfully on an ad-hoc basis to that can handle data entry functions, and maintain help with the administration of particular trials. an on-line data base that is accessible by an easySuch systems obviously run into problems in the to-use query language are commercially available, majority of real-life situations, where groups of However, they often are not appropriate for use in patients are being treated according to a variety of different protocols m a single institution. Even clinical research without modification, not only where single protocols are used sequentially, users because of their expense, but also because a carefully customized user interface is required in the want to learn how to use a system that will be clinical trial setting, generally applicable, rather than learning how to use a new computer system each time a new Important work in using a comprehensive data treatment protocol is introduced. base management approach to aid in clinical trials has been carried out. However, at least in one case, 3.4. User-oriented systems the 'Oncocin' system [5] , the data base management system forms a subset of a larger package Few sv,tems such as the one described in the that incorporates artificial intelligence techniques next section are documented in ;he literature, and to allow the system to advise the clinician on such only a few commercially available systems that ma:ters as formulating a therapeutic regimen, or purport tc have the required functions are on the determining the required interval between patient market. visits.
Bill et al. 161 have described a system installed
In our opinion, the designers of such systems at the Ma?¢o Clinic, and have published a descriphave not had to resort to artificial inteiligente tion of it~i implementation and user acceptance. techniques to solve user-perceived information However. the environment in which this sy,,tem handling problems; rather, the designers have prooperates is not typical, nn that it depends on the vided a 'superset' of functional capabilities that existence of other locally developec, software, and represents an interesting artificial intelligence apon interaction with an 'Institutional Data Base'. plication, but not a capability which clinicians While the development costs were estimated at have identified as being desirable, it may or may $35 000, it seems likely that significant additional not be demonstrated in the future that the use of expenses would be in~:urred if the system were to such advanced systems improves patient care. but be set up elsewhere, independent of the computing at this time many clinicians simply want funcresources .3f the Mayo Clinic. tional 'no-frilr data management support to assist thorn in clinical trials administration, without 4. 'PROTOCOL MANAGEMENT SYSTEM" simultaneously becoming involved in separate re-(PMS): A NEW COMPUTER SYSTEM TO search addressing the question of the possible use-AID WiTH DATA MANAGEMENT IN fulness of artificial intelligence aids to patient CLINICAL RESEARCH management.
Some ambitious systems endeavour to enable 4.1. Design objectives general practitioners to take over functions previously performed b) specialists, or otherwise change Our goal was to design a computer system that the patient !oad of participating physicians. Such would employ modern data base management 24g metho¢o to help solve informatmn handling prob-5. While the system is designed primarily to collems as perceived by those involved in clinical lect and analyse data for the purposes of cliniresearch, cal research, provision must be made for optimum utifization of the collected data to help The following summarizes our geneial design justify the cost of the system. Sample 'spin-off objectives:
benefits include billing, appointment schedul-1. The system must be cost-effective. It should ing and other administrative functions not dihave all the capabilities required to solve the rectly related to the clinical research.
perceived problems, but the temptation to provide extra features that ~re "interesting" but 6. The system must be applicable to clinical renon-essential should be resisted. Artificial intelsearch in both ambulatory patients and in-paligence subsystems are specifically excluded, tients. The capability of serving distant users simply because they are not required to provide with remote terminals must ~:e provided.
the functional capabilities desired by :he clini-7. Confidentiality provisions must include passcai researchers we have interviewed. Indeed. ~me physicians considered "computer-aided word protection, and be equivalent to, or superion to standards of protection present in condecision making" as undesirable from their point of view. for reasons related to ethical, medicoventional medical record systems.
legal, and patient-acceptance considerations. 8. The software development costs must be miniWe realize that documenting the possible costmized by using appropriate commercially availeffectiveness of the system will be difficult. This able data base management systems. A degree of hardware independence is desirable, and this is because PMS will provide services that were previously absent, rather tilan simply automatcan also be achieved by the use of such systems. ing functions that were previously performed by secretarial staff. At the very least, we believe
Functional capab, lities
that the impression of initial users with regards to the system's economic justification should be
Accepting and indexing definitions of clmZcal
reviewed before the system becomes generally protocols available.
The required treatments and observations over time as specified as specified by the protocol are 2. The data-entry functions must be easily used by accepted in -odified form. Permissible value~ for a physicians avd/or clerical personnel in the large number of ~reatment and response variables milieu of a busy clinic. A screen-based menu (typically in the order of 300) are defined. This format is considered acceptable, task is complex, but it would only be done once, at the initiation of a protocol. 3. The data base access and analysis function At this time, the designer of the protocol also should be usable by these physicians who have supplies a textual description of it, and the kinds familiarized themselve~ with the query Innof patients it is intended to treat (so-called 'eligiguage, bility criteria'). This is used to enable the system to maintain an index of current protocols, which can 4. The. system must nov be specific to a given later be displayed on request. Participating physiprotocol: it must be able to simuhaneousl,¢ clans may use this index to re~iew a~! protocols manage different patients on a variety of protoactive at any given time, to determine if a newlycols. individual patients must be allowed to be referred patient is suitable for entry into any ongotreated on different protocols at different times, ing studies. and to be followed 'off pro.ocol' when reResponsibility for the approval of newly-proquired, posed protocols should be carefull3 delegated, and ongoing clinical trials must be re-evaluated fre-(B) The system must be able to provide a quently. A computer system that aids in the dis-'flowsheet' summary of a patient's course to semination of a poorly-conceived protocol would date This is generally printed for all expected clearly be counterproductive, patients before a clinic session begins, but may be printed fer any patient ,~n rcq~e~,t.
Aiding in data collection while patients are (C)
The physician may assign a patient to a treatbeing treated ment protocol of his choice, provided that the This represents a key functior~ of the system, pro:ocol has been defined for the system. He from the user point of view. While our underlying may also change protocols, or decide to dismotivation was simply to provide a facility to continue protocol-defined treatment, but conconveniently capture clinical data as the trial protinue to follow the patient, eWe anticipate gresses, we have found that users will make use of that these capabilities will be used at about the stored data not only for the periodic evalua-10~ of physician-patient enc,',unte:s, t.hose tion of the trial results, but also to aid in the where major treatment decisions are taken.) da)-t~>-day mangement of individual patients. For example, a patient's weight or serum cholesterol (D) The system mu:a inform the user of required may have been entered as required by a protocol treatments and observations for a specific paevaluating a new drug -this data may be retrieved tient on a given day, according to the relevant by a physician at a subsequent follow-up visit to protocol. The objective here is simply to make evaluate a patient's progress, long before it is used the physician aware of protocol requirements at the conclusion of the trial to help judge the • for a specific patient at a given time. The efficacy of the new drug.
physician then acts as he sees fit, and if he must violate an aspect of the protocol because of a particular situation, he may do so. docuThus, by entering data into the system, a user is meriting his action using the capability denot only contributing to the clinical trial, bat also scribed under (F) below. Patient exclusion ~s making data available for easy access in day-tofrom the aggregate ana!ysis of the clinical day patient mangement. This represents a major trial, it necessary, i:, carried out when the trial 'spin-off' benefit, data is analystd. (Unlike the Oncocin System [5] , no effort is made to translate the general Specific function.d capabilities related to the rules of treatment as specified in tr;Jdition~,l routine use of the sy ;tern in the clinic or office are protocol descriptions to ,pecific pre,,cription,, listed below, for a certain patient. For example, if a prt,tocol states 'give 10 mg cyclophosphamide/kg patic;~t weight intravenously, provided that (A) The system mu~t be capable of 'recognition' the white blood cell count is > 5000 and that of patients, given name or number. This imthere are no contraindications', an Oncocinplies the ability to display demographic data like system might review the protocol together on a patient, the treatment protocol (if any) with pattent data and suggest 'give 700 mg currently being used, as well as the number of cyciophosphamide'. PMS has more limited days elapsed since the patient was entered objectives -simply to make the protocol into the clinical trial. A brief statement of statements available to the physician as he diagnosis and previous treatment also forms would find them if he had to look them up in part of the identifying information. All this a manual. Interpretation of the protocol for a information can be updated or corrected as specific patient remains the responsibilit~ of necessary. The elapsed ti,,'ae variable is autothe phx.~ician, not of the system, because we matically kept up to date for each patient by feel that this is preferred by both the physithe system, clans and the patients.)
(E) The user, is allowed to enter values for any or more protocols for treating a single condition observation variables defined for the patient's will be compared. Note that while many of the protocol, even if the recording of these values capabilities listed in section 4.2.2 are used frein not mandatory according to the protocol, quently by doctors and assistants at the time of Provision is made for the recording of a patient visits, the capabilities related 1o protocol 'pending' value, to deal with situations where, definition and to data analysis are generally used for example, a blood test has been ordered, only by trial coordinators, and are used relatively but the result is not yet available, rarely. Nevertheless, it is these capabilities that represent the "ra-son d'etre' of the system. (F) The user is allowed to enter values for treatUsers must be able to use a query language to mettt variables to describe treatments actually extract and display subsets of patients of interest, administered. The system does not assume and a report generating capability must be availathat protocol-specified treatments are always ble. Data extracted in this way naturally leads to exactly prescribed, or that these are the only an analysis of the results of a clinical trial. Provi. treatments the patient receives, sion must be made to enable data to be passed to online statistical packages for further calculations (G) On request, the system has the capability to as reqmred. prompt the user to supply missing 'compulsory" data items that have not been entered 4.3. Implementation considera:ions [7] in the pa'~ t. in case they have become available since the last visit, in order to provide required capabilities, we make use of commercially available sof:ware (H) Physicians may request immedi2te retrieval of packages that provide data base managemer:~ and any previously entered data item. As menquery ianguage functions. As mentioned in the tioned previously, the ability to answer quesintroduction, we feel that the cost-effective solutions such a "What was Mr. S,r,;.'h's last hetion to nlany information handling problems permoglobin?' represents an important "spin-off" ceived by physicians lies in the successful applicabenefit for many users, tion of currently available hardware and software preducts. (Many physicians, disappointed with (!) The sys:em must on request state t!,: maxicurrently used systems, feel that their informationmum peri,~l of time that can elapse beJore the handling problems must await fundamental adnext visit, according to the relevant treatment vances in Computer Science for their solution.) protocol. In practice, the system responds by Systems based on larger microcomputers or reporting a time period such as 'two weeks" or minicomputers would be suitable for clinical re-"one month', and allows the doctor and the searchers that are caring for about 500 patients, patient to agree on a specific d,~c. Extra and are employing ;'.bout a dozen protocols. We visits, beyond those "required" b) protocol, estimate that initial hardware and software costs can also be booked, would be in the $70000 (U.S.) range for such an implementation. ~J) The system must retain data on "dropouts'.
A suitable configuration for a dec'icated system whether due to death or other factors. Io allo~ to serve a patient group of this size :oald include for their inco, poration it, subsequent analysis, h~gh-level application-specific software, and a commercially available data base management
Aidin~ m analrsis of coliected data
Fackage that would be compatible with the multiuser time-sharing environmem provided by a At various interim points, and ~t the conclusion vendor-supplied operating system. Hard~are of ~, clinical trial, administrators will want to rewould include a processing unit, hard disk directview the aggregate data accumulated. Often, two access raemo~w, a printer, several video terminals with keyboards, and telephone-network compatiIn the past clinical research was ~:arried out ble modems. Telecommunication access to a large without computer-aided data processing. We have computer facility would be desirable to gain access reviewed various trends that will tend to increase not only to magnetic tape facilities for archiving interest in computer methodology oa the part of purposes, but also to interactive statistical softclinical researchers, and we c.qn expect that further ware that might be required in the further analysis computer systems to aid in clinical trial manageof data collected and presented by PMS. ment will be developed. Such sys,.ems may be "Fne system could also be implemented on a easier to cost-jestify than larger, rr:ore expensive larger mainframe, and made available to individ-'hospital information systems', because they are ual users by means of public data networks. Such specifically targeied to help with some of the most an implementation would be more expensive, but labour-intensive medical informat;on management would be justifiable if a large number of users problems that exist. were to be serviceat.
Hardware costs are not prohibitive: challenges The cost of a PMS intplementation on a dediinclude keeping software development costs to ;~ cated system might well be justified by a group of minimum, and ensuring that capabilities provided physicians participating in clinical trials, while a coincide with specifications of intended users. centralized implementation might be appropriate Close liais.vn between physicians and computer for central orgamzers of multiple clinical trials, experts is a critical factor in the development of such as drug companies, universities, or governsuccessful sy~teros, and poor results must be exmerit agencies, pected if those who design programs do not have a In either case, one of the challenges to be faced thorough appreciation of information-handling for the successful establishment of a protocol problems as perceived by medical personnel. It is management system would be the careful integrathe solution of these problems, rather than the tion of the new system with existing 'manual' or mere introduction of new technology, that clinical computerized medical record-keeping methods, researchers are seeking. This step must be individualized for each institution. to minimize duplication of data-handling, and max.mize user acceptance.
